Antioxidant Drug Tempol Promotes Functional Metabolic Changes in the Gut Microbiota

Jingwei Cai, Limin Zhang, Richard A. Jones, Jared B. Correll, Emmanuel Hatzakis, Philip B. Smith, Frank J. Gonzalez, Andrew David Patterson

Research output: Contribution to journalArticle

10 Citations (Scopus)

Abstract

Recent studies have identified the important role of the gut microbiota in the pathogenesis and progression of obesity and related metabolic disorders. The antioxidant tempol was shown to prevent or reduce weight gain and modulate the gut microbiota community in mice; however, the mechanism by which tempol modulates weight gain/loss with respect to the host and gut microbiota has not been clearly established. Here we show that tempol (0, 1, 10, and 50 mg/kg p.o. for 5 days) decreased cecal bacterial fermentation and increased fecal energy excretion in a dose-dependent manner. Liver 1H NMR-based metabolomics identified a dose-dependent decrease in glycogen and glucose, enhanced glucogenic and ketogenic activity (tyrosine and phenylalanine), and increased activation of the glycolysis pathway. Serum 1H NMR-based metabolomics indicated that tempol promotes enhanced glucose catabolism. Hepatic gene expression was significantly altered as demonstrated by an increase in Pepck and G6pase and a decrease in Hnf4a, ChREBP, Fabp1, and Cd36 mRNAs. No significant change in the liver and serum metabolomic profiles was observed in germ-free mice, thus establishing a significant role for the gut microbiota in mediating the beneficial metabolic effects of tempol. These results demonstrate that tempol modulates the gut microbial community and its function, resulting in reduced host energy availability and a significant shift in liver metabolism toward a more catabolic state.

Original languageEnglish (US)
Pages (from-to)563-571
Number of pages9
JournalJournal of Proteome Research
Volume15
Issue number2
DOIs
StatePublished - Feb 5 2016

Fingerprint

Antioxidants
Metabolomics
Pharmaceutical Preparations
Liver
Weight Gain
Nuclear magnetic resonance
Glucose
Glycolysis
Serum
Phenylalanine
Glycogen
Metabolism
Gene expression
Fermentation
Tyrosine
Gastrointestinal Microbiome
tempol
Weight Loss
Obesity
Chemical activation

All Science Journal Classification (ASJC) codes

  • Biochemistry
  • Chemistry(all)

Cite this

Cai, Jingwei ; Zhang, Limin ; Jones, Richard A. ; Correll, Jared B. ; Hatzakis, Emmanuel ; Smith, Philip B. ; Gonzalez, Frank J. ; Patterson, Andrew David. / Antioxidant Drug Tempol Promotes Functional Metabolic Changes in the Gut Microbiota. In: Journal of Proteome Research. 2016 ; Vol. 15, No. 2. pp. 563-571.
@article{b78fa507496c48c599bea2737a532366,
title = "Antioxidant Drug Tempol Promotes Functional Metabolic Changes in the Gut Microbiota",
abstract = "Recent studies have identified the important role of the gut microbiota in the pathogenesis and progression of obesity and related metabolic disorders. The antioxidant tempol was shown to prevent or reduce weight gain and modulate the gut microbiota community in mice; however, the mechanism by which tempol modulates weight gain/loss with respect to the host and gut microbiota has not been clearly established. Here we show that tempol (0, 1, 10, and 50 mg/kg p.o. for 5 days) decreased cecal bacterial fermentation and increased fecal energy excretion in a dose-dependent manner. Liver 1H NMR-based metabolomics identified a dose-dependent decrease in glycogen and glucose, enhanced glucogenic and ketogenic activity (tyrosine and phenylalanine), and increased activation of the glycolysis pathway. Serum 1H NMR-based metabolomics indicated that tempol promotes enhanced glucose catabolism. Hepatic gene expression was significantly altered as demonstrated by an increase in Pepck and G6pase and a decrease in Hnf4a, ChREBP, Fabp1, and Cd36 mRNAs. No significant change in the liver and serum metabolomic profiles was observed in germ-free mice, thus establishing a significant role for the gut microbiota in mediating the beneficial metabolic effects of tempol. These results demonstrate that tempol modulates the gut microbial community and its function, resulting in reduced host energy availability and a significant shift in liver metabolism toward a more catabolic state.",
author = "Jingwei Cai and Limin Zhang and Jones, {Richard A.} and Correll, {Jared B.} and Emmanuel Hatzakis and Smith, {Philip B.} and Gonzalez, {Frank J.} and Patterson, {Andrew David}",
year = "2016",
month = "2",
day = "5",
doi = "10.1021/acs.jproteome.5b00957",
language = "English (US)",
volume = "15",
pages = "563--571",
journal = "Journal of Proteome Research",
issn = "1535-3893",
publisher = "American Chemical Society",
number = "2",

}

Antioxidant Drug Tempol Promotes Functional Metabolic Changes in the Gut Microbiota. / Cai, Jingwei; Zhang, Limin; Jones, Richard A.; Correll, Jared B.; Hatzakis, Emmanuel; Smith, Philip B.; Gonzalez, Frank J.; Patterson, Andrew David.

In: Journal of Proteome Research, Vol. 15, No. 2, 05.02.2016, p. 563-571.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Antioxidant Drug Tempol Promotes Functional Metabolic Changes in the Gut Microbiota

AU - Cai, Jingwei

AU - Zhang, Limin

AU - Jones, Richard A.

AU - Correll, Jared B.

AU - Hatzakis, Emmanuel

AU - Smith, Philip B.

AU - Gonzalez, Frank J.

AU - Patterson, Andrew David

PY - 2016/2/5

Y1 - 2016/2/5

N2 - Recent studies have identified the important role of the gut microbiota in the pathogenesis and progression of obesity and related metabolic disorders. The antioxidant tempol was shown to prevent or reduce weight gain and modulate the gut microbiota community in mice; however, the mechanism by which tempol modulates weight gain/loss with respect to the host and gut microbiota has not been clearly established. Here we show that tempol (0, 1, 10, and 50 mg/kg p.o. for 5 days) decreased cecal bacterial fermentation and increased fecal energy excretion in a dose-dependent manner. Liver 1H NMR-based metabolomics identified a dose-dependent decrease in glycogen and glucose, enhanced glucogenic and ketogenic activity (tyrosine and phenylalanine), and increased activation of the glycolysis pathway. Serum 1H NMR-based metabolomics indicated that tempol promotes enhanced glucose catabolism. Hepatic gene expression was significantly altered as demonstrated by an increase in Pepck and G6pase and a decrease in Hnf4a, ChREBP, Fabp1, and Cd36 mRNAs. No significant change in the liver and serum metabolomic profiles was observed in germ-free mice, thus establishing a significant role for the gut microbiota in mediating the beneficial metabolic effects of tempol. These results demonstrate that tempol modulates the gut microbial community and its function, resulting in reduced host energy availability and a significant shift in liver metabolism toward a more catabolic state.

AB - Recent studies have identified the important role of the gut microbiota in the pathogenesis and progression of obesity and related metabolic disorders. The antioxidant tempol was shown to prevent or reduce weight gain and modulate the gut microbiota community in mice; however, the mechanism by which tempol modulates weight gain/loss with respect to the host and gut microbiota has not been clearly established. Here we show that tempol (0, 1, 10, and 50 mg/kg p.o. for 5 days) decreased cecal bacterial fermentation and increased fecal energy excretion in a dose-dependent manner. Liver 1H NMR-based metabolomics identified a dose-dependent decrease in glycogen and glucose, enhanced glucogenic and ketogenic activity (tyrosine and phenylalanine), and increased activation of the glycolysis pathway. Serum 1H NMR-based metabolomics indicated that tempol promotes enhanced glucose catabolism. Hepatic gene expression was significantly altered as demonstrated by an increase in Pepck and G6pase and a decrease in Hnf4a, ChREBP, Fabp1, and Cd36 mRNAs. No significant change in the liver and serum metabolomic profiles was observed in germ-free mice, thus establishing a significant role for the gut microbiota in mediating the beneficial metabolic effects of tempol. These results demonstrate that tempol modulates the gut microbial community and its function, resulting in reduced host energy availability and a significant shift in liver metabolism toward a more catabolic state.

UR - http://www.scopus.com/inward/record.url?scp=84957716517&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84957716517&partnerID=8YFLogxK

U2 - 10.1021/acs.jproteome.5b00957

DO - 10.1021/acs.jproteome.5b00957

M3 - Article

C2 - 26696396

AN - SCOPUS:84957716517

VL - 15

SP - 563

EP - 571

JO - Journal of Proteome Research

JF - Journal of Proteome Research

SN - 1535-3893

IS - 2

ER -